Triple-antiretroviral prophylaxis to prevent mother-to-child HIV transmission through breastfeeding-the Kisumu Breastfeeding Study, Kenya: A clinical trial

PLoS Medicine

Volumn 8, Issue 3, 2011, Pages

  Thomas, Timothy K ^a,b   Masaba, Rose ^b   Borkowf, Craig B ^a   Ndivo, Richard ^b   Zeh, Clement ^a,b   Misore, Ambrose ^c   Otieno, Juliana ^d   Jamieson, Denise ^a   Thigpen, Michael C ^a   Bulterys, Marc ^a   Slutsker, Laurence ^b,e   de Cock, Kevin M ^a,b   Amornkul, Pauli N ^a,b   Greenberg, Alan E ^a   Fowler, Mary Glenn ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b KENYA MEDICAL RESEARCH INSTITUTE   (Kenya)

^c MINISTRY OF HEALTH   (Kenya)

^d New Nyanza Provincial General Hospital   (Kenya)

^e CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LAMIVUDINE PLUS ZIDOVUDINE; NELFINAVIR; NEVIRAPINE; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ADULT; ANEMIA; ARTICLE; BREAST FEEDING; CD4 LYMPHOCYTE COUNT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DRUG FATALITY; DRUG SAFETY; DRUG SUBSTITUTION; DRUG TOLERABILITY; DRUG WITHDRAWAL; FEMALE; GESTATIONAL AGE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT; INFANT MORTALITY; KENYA; LACTATION; LIVER TOXICITY; MAJOR CLINICAL STUDY; MALARIA; MALE; MATERNAL MORTALITY; MORTALITY; NEUTROPENIA; OPPORTUNISTIC INFECTION; PATIENT COMPLIANCE; PHASE 2 CLINICAL TRIAL; PNEUMONIA; PUERPERIUM; RASH; RESPIRATORY FAILURE; RISK FACTOR; SINGLE DRUG DOSE; STEVENS JOHNSON SYNDROME; THIRD TRIMESTER PREGNANCY; VERTICAL TRANSMISSION; VIRUS LOAD; VIRUS TRANSMISSION; ADOLESCENT; CLINICAL TRIAL; DELIVERY; DEMOGRAPHY; DISEASE TRANSMISSION; HUMAN IMMUNODEFICIENCY VIRUS 1; KAPLAN MEIER METHOD; MOTHER; NEWBORN; PHYSIOLOGY; PREGNANCY; VIROLOGY;

ADOLESCENT; ADULT; ANTI-HIV AGENTS; BREAST FEEDING; DELIVERY, OBSTETRIC; DEMOGRAPHY; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; INFANT, NEWBORN; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; KAPLAN-MEIER ESTIMATE; KENYA; MEDICATION ADHERENCE; MOTHERS; PREGNANCY; YOUNG ADULT;

EID: 79953696805     PISSN: 15491277     EISSN: 15491676     Source Type: Journal    
DOI: 10.1371/journal.pmed.1001015     Document Type: Article

References (35)

1. UNAIDS (2010) UNAIDS Report on the Global AIDS Epidemic. http://www.unaids.org/globalreport/default.htm. Accessed 24 January 2011.
2. De Cock KM, Fowler MG, Mercier E, de Vincenzi I, Saba J, et al. (2000) Prevention of mother-to-child HIV transmission in resource-poor countries: translating research into policy and practice. JAMA 283: 1175-1182.
3. Van de Perre P, Simonon A, Msellati P, Hitimana DG, Vaira D, et al. (1991) Postnatal transmission of human immunodeficiency virus type 1 from mother to infant. A prospective cohort study in Kigali, Rwanda. N Engl J Med 325: 593-598.
4. Kreiss J, (1997) Breastfeeding and vertical transmission of HIV-1. Acta Paediatr Suppl 421: 113-117.
5. Bulterys M, Fowler MG, Van Rompay KK, Kourtis AP, (2004) Prevention of mother-to-child transmission of HIV-1 through breast-feeding: past, present, and future. J Infect Dis 189: 2149-2153.
6. The PETRA Study Team (2002) Efficacy of three short-course regimens of zidovudine and lamivudine in preventing early and late transmission of HIV-1 from mother to child in Tanzania, South Africa, and Uganda (Petra study): a randomised, double-blind, placebo-controlled trial. Lancet 359: 1178-1186.
7. Dabis F, Bequet L, Ekouevi DK, Viho I, Rouet F, et al. (2005) Field efficacy of zidovudine, lamivudine and single-dose nevirapine to prevent peripartum HIV transmission. AIDS 19: 309-318.
8. Jackson JB, Musoke P, Fleming T, Guay LA, Bagenda D, et al. (2003) Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: 18-month follow-up of the HIVNET 012 randomised trial. Lancet 362: 859-868.
9. Leroy V, Ekouevi DK, Becquet R, Viho I, Dequae-Merchadou L, et al. (2008) 18-Month effectiveness of short-course antiretroviral regimens combined with alternatives to breastfeeding to prevent HIV mother-to-child transmission. PLoS ONE 3: e1645 doi:10.1371/journal.pone.0001645.
10. WHO, UNICEF, UNAIDS, UNFPA (1998) HIV and infant feeding: a guide for health-care managers and supervisors. www.who.int/nutrition/publications/hivaids/9241591234/en/. Accessed 24 January 2011.
11. WHO, UNICEF, UNFPA, UNAIDS (2006) HIV and infant feeding: update based on the technical consultation held on behalf of the Inter-agency Team (IATT) on Prevention of HIV Infections in Pregnant Women, Mothers and their Infants. 25-27 October 2006; http://whqlibdoc.who.int/publications/2007/9789241595964_eng.pdf. Accessed 24 January 2011.
12. Boehringer Ingelheim Pharmaceuticals Inc (2005) Nevirapine (Viramune) revised label Ridgefield (Connecticut, United States of America) Boehringer Ingelheim Pharmaceuticals, Inc.
13. WHO (2003) Scaling up antiretroviral therapy in resource-limited settings: treatment guidelines for a public health approach. http://www.who.int/hiv/pub/prev_care/en/arvrevision2003en.pdf. Accessed 24 January 2011.
14. Rutenberg N, (2003) Infant feeding counseling within Kenyan and Zambian PMTCT services: how well does it promote good feeding practices? Washington (D.C.) Population Council.
15. NIH, NIAID (1992) Division of AIDS table for grading severity of adult adverse experiences. http://rcc.tech-res.com/Document/safetyandpharmacovigilance/ToxicityTables_Adult_TRP_v01a.pdf. Accessed 24 January 2011.
16. NIH, NIAID (1994) Division of AIDS table for grading severity of pediatric adverse events. http://rcc.tech-res.com/Document/safetyandpharmacovigilance/ToxicityTables_Pediatric_Over3MonthsAge_v03.pdf and http://rcc.tech-res.com/Document/safetyandpharmacovigilance/ToxicityTables_Pediatric_Under3MonthsAge_v02.pdf. Accessed 24 January 2011.
17. Boehringer Ingelheim Pharmaceuticals Inc (2008) Prescribing information: VIRAMUNE (nevirapine) Ridgefield (Connecticut, United States of America) Boehringer Ingelheim Pharmaceuticals, Inc.
18. GlaxoSmithKline (2007) Prescribing information: Combivir (lamivudine/zidouvdine) tablets Research Triangle Park, (North Carolina, United States) GlaxoSmithKline.
19. Ayisi JG, van Eijk AM, Newman RD, ter Kuile FO, Shi YP, et al. (2004) Maternal malaria and perinatal HIV transmission, western Kenya. Emerg Infect Dis 10: 643-652.
20. Kilewo C, Karlsson K, Ngarina M, Massawe A, Lyamuya E, et al. (2009) Prevention of mother-to-child transmission of HIV-1 through breastfeeding by treating mothers with triple antiretroviral therapy in Dar es Salaam, Tanzania: the Mitra Plus study. J Acquir Immune Defic Syndr 52: 406-416.
21. Chasela CS, Hudgens MG, Jamieson DJ, Kayira D, Hosseinipour MC, et al. (2010) Maternal or infant antiretroviral drugs to reduce HIV-1 transmission. N Engl J Med 362: 2271-2281.
22. de Vincenzi I, (2009) Triple-antiretroviral (ARV) prophylaxis during pregnancy and breastfeeding compared to short-ARV prophylaxis to prevent mother-to-child transmission of HIV-1 (MTCT): the Kesho Bora randomized controlled clinical trial in five sites in Burkina Faso, Kenya. In: Proceedings of the 2009 International AIDS Society Conference; Cape Town, South Africa.
23. Peltier CA, Ndayisaba GF, Lepage P, van Griensven J, Leroy V, et al. (2009) Breastfeeding with maternal antiretroviral therapy or formula feeding to prevent HIV postnatal mother-to-child transmission in Rwanda. AIDS 23: 2415-2423.
24. Shapiro RL, Hughes MD, Ogwu A, Kitch D, Lockman S, et al. (2010) Antiretroviral regimens in pregnancy and breast-feeding in Botswana. N Engl J Med 362: 2282-2294.
25. Burr CK, Lampe MA, Corle S, Margolin FS, Abresh C, et al. (2007) An end to perinatal HIV: success in the US requires ongoing and innovative efforts that should expand globally. J Public Health Policy 28: 249-260.
26. van Eijk AM, Bles HM, Odhiambo F, Ayisi JG, Blokland IE, et al. (2006) Use of antenatal services and delivery care among women in rural western Kenya: a community based survey. Reprod Health 3: 2.
27. Morgan MC, Masaba RO, Nyikuri M, Thomas TK, (2010) Factors affecting breastfeeding cessation after discontinuation of antiretroviral therapy to prevent mother-to-child transmission of HIV. AIDS Care 22: 866-873.
28. Kuhn L, Aldrovandi GM, Sinkala M, Kankasa C, Semrau K, et al. (2008) Effects of early, abrupt weaning on HIV-free survival of children in Zambia. N Engl J Med 359: 130-141.
29. Zeh C, Weidle PJ, Nafisa L, Lwamba HM, Okonji J, et al. (2011) HIV-1 drug resistance emergence among breastfeeding infants born to HIV-infected mothers taking triple-antiretroviral prophylaxis for prevention of mother-to-child transmission. PLoS Med 8: e1000430 doi:10.1371/journal.pmed.1000430.
30. Ouyang DW, Brogly SB, Lu M, Shapiro DE, Hershow RC, et al. (2010) Lack of increased hepatotoxicity in HIV-infected pregnant women receiving nevirapine compared with other antiretrovirals. AIDS 24: 109-114.
31. Brooks J, Thomas T, Masaba R, Amornkul P, Mwaengo D, et al. (2005) Neutropenia in HIV-infected Kenyan women receiving antiretroviral therapy to prevent mother-to-child HIV transmission. In: Proceedings of the 12th Conference on Retroviruses and Opportunistic Infections; February; Boston, Massachusetts, United States.
32. Ministry of Health, Kenya (2006) Division of Vaccines and Immunization- Multi Year Plan, 2006-2010 Nairobi Ministry of Health, Kenya.
33. WHO (2008) WHO Expert Consultation on new and emerging evidence on the use of antiretroviral drugs for the prevention of mother-to-child transmission of HIV. 17-19 November, 2008, Geneva: WHO. http://www.who.int/child_adolescent_health/documents/media/pmtct_consultation_2008.pdf.
34. WHO (2010) Antiretroviral drugs for treating pregnant women and preventing HIV infection in infants: recommendations for a public health approach Geneva WHO.
35. Fowler MG, et al. (2009) IMPAACT P1077: The PROMISE Study (Promoting Maternal and Infant Survival Everywhere), synopsis. Available:http://www.impaactgroup.org/files/IMPAACT_P1077_Synopsis.doc.